Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Establishing pathways to precision genetic therapies for children with medical complexity

EF 2023-24

Résumé
Children with medical complexity (CMC) are a diverse population with a spectrum of severe conditions. These children spend much of their lives receiving care in and out of the hospital and often depend on life-sustaining devices, resulting in substantial use of Canada's healthcare system. Most CMC are suspected to have underlying genetic conditions. Making the right diagnosis is both important and challenging, but when limited to the genetic testing available in clinics, healthcare providers and families can remain in the dark for too long. Our goal is to use cutting-edge technologies to discover novel genetic conditions, understand the pathway from DNA difference to medical complexity, and facilitate the development of personalized care for CMC and their families. We will use advanced genetic methods to read the entire DNA of CMC and their family members to pinpoint differences causing never-before-described genetic conditions. Customized experiments will be designed to understand how specific DNA differences cause disease, such as by using DNA editing techniques to recreate a child's condition in a model system. We will identify CMC who could benefit from a type of personalized care, referred to as an antisense oligonucleotide (ASO), which targets the cause of the condition at the genetic level and has gained significant traction in recent years. Results from this study will advance our understanding of medical complexity in children. The findings promise to help translate new genetic technologies into clinical use, advance personalized care approaches, and inform practice and policy implemented in Canada. By providing insight into the human genetic code, the results of this study may also help identify the genetic causes and mechanisms of other health problems.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
506378
Name
Newton Logan W
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Establishing pathways to precision genetic therapies for children with medical complexity
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Antisense Oligonucleotide Treatment; Caregiver Perspectives; Children With Medical Complexity; Paediatrics; Precision Medicine; Translational Genomics
Abstract
Children with medical complexity (CMC) are a diverse population with a spectrum of severe conditions. These children spend much of their lives receiving care in and out of the hospital and often depend on life-sustaining devices, resulting in substantial use of Canada's healthcare system. Most CMC are suspected to have underlying genetic conditions. Making the right diagnosis is both important and challenging, but when limited to the genetic testing available in clinics, healthcare providers and families can remain in the dark for too long. Our goal is to use cutting-edge technologies to discover novel genetic conditions, understand the pathway from DNA difference to medical complexity, and facilitate the development of personalized care for CMC and their families. We will use advanced genetic methods to read the entire DNA of CMC and their family members to pinpoint differences causing never-before-described genetic conditions. Customized experiments will be designed to understand how specific DNA differences cause disease, such as by using DNA editing techniques to recreate a child's condition in a model system. We will identify CMC who could benefit from a type of personalized care, referred to as an antisense oligonucleotide (ASO), which targets the cause of the condition at the genetic level and has gained significant traction in recent years. Results from this study will advance our understanding of medical complexity in children. The findings promise to help translate new genetic technologies into clinical use, advance personalized care approaches, and inform practice and policy implemented in Canada. By providing insight into the human genetic code, the results of this study may also help identify the genetic causes and mechanisms of other health problems.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Newton, Logan W
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~